(Q37873541)

24 August 2017

1 reference

title

The clinical management of tumour lysis syndrome in haematological malignancies (English)

1 reference

24 August 2017

Andrew Will

1

1 reference

24 August 2017

Eleni Tholouli

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

9 May 2011

1 reference

British Journal of Haematology

24 August 2017

published in

1 reference

24 August 2017

volume

154

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

3-13

1 reference

Acute renal failure from spontaneous acute tumor lysis syndrome: a case report and review

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Management of hyperuricemia with rasburicase review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Hemolysis and methemoglobinemia secondary to rasburicase administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Tumour lysis syndrome: new therapeutic strategies and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding hodgkin disease) associated with and without acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Acute uric acid nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Tumor lysis syndrome: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

PREVENTION OF HYPERURICEMIA IN LEUKEMIA AND LYMPHOMA: USE OF ALOPURINOL, A XANTHINE OXIDASE INHIBITOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Cloning, purification, and partial characterization of Bacillus subtilis urate oxidase expressed in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Rasburicase: a potent uricolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

The management of tumor lysis syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Management of acute tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

The role of uric acid in protection against peroxynitrite-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Colonic necrosis following sodium polystyrene sulfonate (Kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

Hyperphosphatemia, Hyperphosphaturia and Hypocalcemia in Acute Lymphoblastic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08697.X

10.1111/J.1365-2141.2011.08697.X

21 January 2018

Identifiers

DOI

1 reference

release_hdzehhclkzd2bgaesx4haov6ja

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hdzehhclkzd2bgaesx4haov6ja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference